BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1131 related articles for article (PubMed ID: 19910634)

  • 21. Enrichment of Triglyceride-Rich Lipoproteins with Apolipoprotein C-I Is Positively Associated with Their Delayed Plasma Clearance Independently of Other Transferable Apolipoproteins in Postmenopausal Overweight and Obese Women.
    Wassef H; Bissonnette S; Dufour R; Davignon J; Faraj M
    J Nutr; 2017 May; 147(5):754-762. PubMed ID: 28356429
    [No Abstract]   [Full Text] [Related]  

  • 22. Further characterization of the metabolic properties of triglyceride-rich lipoproteins from human and mouse apoC-III transgenic mice.
    Aalto-Setälä K; Weinstock PH; Bisgaier CL; Wu L; Smith JD; Breslow JL
    J Lipid Res; 1996 Aug; 37(8):1802-11. PubMed ID: 8864964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of human apolipoprotein A-II in mice induces hypertriglyceridemia due to defective very low density lipoprotein hydrolysis.
    Boisfer E; Lambert G; Atger V; Tran NQ; Pastier D; Benetollo C; Trottier JF; Beaucamps I; Antonucci M; Laplaud M; Griglio S; Chambaz J; Kalopissis AD
    J Biol Chem; 1999 Apr; 274(17):11564-72. PubMed ID: 10206963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human apolipoprotein A-II associates with triglyceride-rich lipoproteins in plasma and impairs their catabolism.
    Dugué-Pujol S; Rousset X; Pastier D; Quang NT; Pautre V; Chambaz J; Chabert M; Kalopissis AD
    J Lipid Res; 2006 Dec; 47(12):2631-9. PubMed ID: 16990646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-density lipoprotein subpopulation profiles in lipoprotein lipase and hepatic lipase deficiency.
    Tani M; Horvath KV; Lamarche B; Couture P; Burnett JR; Schaefer EJ; Asztalos BF
    Atherosclerosis; 2016 Oct; 253():7-14. PubMed ID: 27573733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyroxine binding to the apolipoproteins of high density lipoproteins HDL2 and HDL3.
    Benvenga S; Cahnmann HJ; Rader D; Kindt M; Robbins J
    Endocrinology; 1992 Dec; 131(6):2805-11. PubMed ID: 1446618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paradoxical exacerbation of combined hyperlipidemia in human apolipoprotein A-II transgenic mice treated with fenofibrate.
    Ribas V; Palomer X; Roglans N; Rotllan N; Fievet C; Tailleux A; Julve J; Laguna JC; Blanco-Vaca F; Escolà-Gil JC
    Biochim Biophys Acta; 2005 Dec; 1737(2-3):130-7. PubMed ID: 16226489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the effect of post-heparin and pre-heparin lipoprotein lipase and hepatic triglyceride lipase on remnant lipoprotein metabolism.
    Shirakawa T; Nakajima K; Shimomura Y; Kobayashi J; Stanhope K; Havel P; Machida T; Sumino H; Murakami M
    Clin Chim Acta; 2015 Feb; 440():193-200. PubMed ID: 25239670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia.
    Escolà-Gil JC; Julve J; Marzal-Casacuberta A; Ordóñez-Llanos J; González-Sastre F; Blanco-Vaca F
    J Lipid Res; 2000 Aug; 41(8):1328-38. PubMed ID: 10946021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postprandial exchange of apolipoprotein C-III between plasma lipoproteins.
    Barr SI; Kottke BA; Mao SJ
    Am J Clin Nutr; 1981 Feb; 34(2):191-8. PubMed ID: 7211723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sialylated isoforms of apolipoprotein C-III and plasma lipids in subjects with coronary artery disease.
    Olivieri O; Chiariello C; Martinelli N; Castagna A; Speziali G; Girelli D; Pizzolo F; Bassi A; Cecconi D; Robotti E; Manfredi M; Conte E; Marengo E
    Clin Chem Lab Med; 2018 Aug; 56(9):1542-1550. PubMed ID: 29652662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Independent regulation of plasma apolipoprotein C-II and C-III concentrations in very low density and high density lipoproteins: implications for the regulation of the catabolism of these lipoproteins.
    Le NA; Gibson JC; Ginsberg HN
    J Lipid Res; 1988 May; 29(5):669-77. PubMed ID: 3411241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormal activation of lipoprotein lipase by non-equilibrating apoC-II: further evidence for the presence of non-equilibrating pools of apolipoproteins C-II and C-III in plasma lipoproteins.
    Tornoci L; Scheraldi CA; Li X; Ide H; Goldberg IJ; Le NA
    J Lipid Res; 1993 Oct; 34(10):1793-803. PubMed ID: 8245727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitation of human apolipoprotein C-III and its subspecie by radioimmunoassay and analytical isoelectric focusing: abnormal plasma triglyceride-rich lipoprotein apolipoprotein C-III subspecie concentrations in hypertriglyceridemia.
    Kashyap ML; Srivastava LS; Hynd BA; Gartside PS; Perisutti G
    J Lipid Res; 1981 Jul; 22(5):800-10. PubMed ID: 7288286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma Apolipoproteins Predicting the Occurrence and Severity of Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus.
    Zhang X; Nie Y; Gong Z; Zhu M; Qiu B; Wang Q
    Front Endocrinol (Lausanne); 2022; 13():915575. PubMed ID: 35937834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel apolipoprotein C-II mimetic peptide that activates lipoprotein lipase and decreases serum triglycerides in apolipoprotein E-knockout mice.
    Amar MJ; Sakurai T; Sakurai-Ikuta A; Sviridov D; Freeman L; Ahsan L; Remaley AT
    J Pharmacol Exp Ther; 2015 Feb; 352(2):227-35. PubMed ID: 25395590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased postprandial high density lipoprotein cholesterol and apolipoproteins A-I and E in normolipidemic smoking men: relations with lipid transfer proteins and LCAT activities.
    Mero N; Van Tol A; Scheek LM; Van Gent T; Labeur C; Rosseneu M; Taskinen MR
    J Lipid Res; 1998 Jul; 39(7):1493-502. PubMed ID: 9684753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [THE LIPOLYSIS IN PHYLOGENETICALLY EARLY LIPOPROTEINS OF LOW DENSITY AND MORE LATER LIPOPROTEINS OF VERY LOW DENSITY: FUNCTION AND DIAGNOSTIC VALUE OF APOE AND APOC-III].
    Rozhkova TA; Titov VN; Amelyushkina VA; Kaba SI; Kukhartchuk VV
    Klin Lab Diagn; 2015 Dec; 60(12):4-14. PubMed ID: 27032246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma lipoprotein distribution of apoC-III in normolipidemic and hypertriglyceridemic subjects: comparison of the apoC-III to apoE ratio in different lipoprotein fractions.
    Fredenrich A; Giroux LM; Tremblay M; Krimbou L; Davignon J; Cohn JS
    J Lipid Res; 1997 Jul; 38(7):1421-32. PubMed ID: 9254067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of apoC-I in apoE-null mice: severe hypertriglyceridemia due to inhibition of hepatic lipase.
    Conde-Knape K; Bensadoun A; Sobel JH; Cohn JS; Shachter NS
    J Lipid Res; 2002 Dec; 43(12):2136-45. PubMed ID: 12454276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.